Veracyte (VCYT) Free Cash Flow (QoQ) (2013 - 2026)
Veracyte (VCYT) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.22% |
| Mar 31, 2026 | -34.95% |
| Dec 31, 2025 | 14.67% |
| Sep 30, 2025 | 45.53% |
| Jun 30, 2025 | 812.19% |
| Mar 31, 2025 | -88.36% |
| Dec 31, 2024 | 26.71% |
| Sep 30, 2024 | -21.20% |
| Jun 30, 2024 | 374.74% |
| Mar 31, 2024 | -284.54% |
| Dec 31, 2023 | -59.34% |
| Sep 30, 2023 | -14.22% |
| Jun 30, 2023 | 554.35% |
| Mar 31, 2023 | -156.57% |
| Dec 31, 2022 | -0.25% |
| Sep 30, 2022 | 2,457.79% |
| Jun 30, 2022 | 102.85% |
| Mar 31, 2022 | -173.19% |
| Dec 31, 2021 | 313.45% |
| Sep 30, 2021 | -293.19% |